Antigenic diversity in Theileria parva in vaccine stabilate and African buffalo
dc.contributor.advisor
Morrison, Ivan
en
dc.contributor.author
Hemmink, Johanneke Dinie
en
dc.contributor.sponsor
Biotechnology and Biological Sciences Research Council (BBSRC)
en
dc.date.accessioned
2014-10-27T14:47:57Z
dc.date.available
2014-10-27T14:47:57Z
dc.date.issued
2014-07-05
dc.description.abstract
Theileria parva is a tick-borne intracellular protozoan parasite which infects cattle
and African buffalo in Eastern and Southern Africa. Cattle may be immunised
against T. parva by the infection and treatment method (ITM), which involves
inoculation with live sporozoites and simultaneous treatment with oxytetracycline.
One such ITM vaccine is the Muguga Cocktail, which is composed of a mixture of
three parasite stocks: Muguga, Serengeti-transformed and Kiambu 5. Although the
vaccine has been used with success in the field in several areas in Eastern Africa,
there is evidence that vaccination using cattle-derived parasites does not always
provide adequate protection against buffalo-derived T. parva. A number of T. parva
antigens recognised by CD8+ T cells from cattle immunised by ITM have been
identified in previous studies. A proportion of these antigens show a high degree of
sequence polymorphism and allelic diversity is believed to be much greater in
buffalo-derived T. parva than in cattle-derived parasites. The present study focussed
on the development and application of a deep sequencing technique for
characterising genotypically heterogeneous T. parva DNA samples. A panel of genes
encoding CD8+ T cell antigens was used as the basis of a multi-locus sequence
typing system (MLST) built upon Roche 454 amplicon sequencing technology. This
system was validated using parasite stocks of known composition and then utilised to
investigate genetic and antigenic diversity in vaccine stabilates and samples derived
from African buffalo. The MLST profile obtained for the Muguga Cocktail stocks
was compared to those of African buffalo in two geographically separated sites and
was also compared with micro/mini-satellite DNA profiles of Muguga Cocktail
stocks.
The three components of the T. parva Muguga Cocktail vaccine were found to have
limited genotypic and antigenic diversity using both methods. The composition of
vaccine batches produced in a single production run (ILRI0801-ILRI0804) was
shown to be relatively consistent. In contrast, the composition of the component
stocks was shown to alter following passage through cattle and ticks. The deep multi-locus
sequence profile and satellite DNA profile established in this study may be
used as a reference for comparison with future vaccine batches. It is suggested that formulation of a new cocktail vaccine containing three parasite clones selected on the
basis of genotypic and antigenic divergence may well provide protection comparable
to that obtained with the Muguga Cocktail. The components of such a vaccine could
readily be distinguished and the composition of vaccine batches monitored, thus
allowing improved quality control and greater consistency of the vaccine.
Genetic and antigenic diversity was found to be very high in parasite populations
from African buffalo from the Kruger National Park, South Africa and the Ol Pejeta
conservancy, Kenya. The estimated average genetic ‘distance’ between any two
alleles in the Kruger National Park and within the Ol Pejeta conservancy was very
similar for all six genes investigated. Many of the identified alleles were ‘private’ to
either the buffalo from Ol Pejeta or the Kruger National Park and many of these
alleles were present in several individuals in one location. Principal co-ordinate
analysis and phylogenetic investigation of several antigen-encoding loci indicated
that extant buffalo parasite populations are geographically sub-structured although
some of the underlying diversity may reflect ‘ancient’ polymorphism in an ancestral
population.
A subset of the CD8+ T cell antigens examined exhibited extensive antigenic
polymorphism while others were highly conserved at the amino acid level. These
conserved genes may represent good candidates for the development of next
generation vaccines, as strain specificity may be overcome if protective CD8+ T cell
responses could be generated against these conserved antigens. This would enable
the use of sub-unit vaccines in areas where cattle co-graze with buffalo.
Theileria sp (buffalo) was identified in cell lines isolated from cattle, indicating that
this parasite can transform bovine lymphocytes and may therefore be implicated in
pathology in cattle. Phylogenetic analysis of T. parva and T. sp (buffalo) clones using
the 5S subunit ribosomal RNA gene, Tp6, Tp7 and Tp8 showed a clear distinction
between the two parasite species. These genes could thus be considered as candidates
for an improved diagnostic test for T. parva in South Africa.
en
dc.identifier.uri
http://hdl.handle.net/1842/9622
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.subject
Theileria parva
en
dc.subject
buffalo
en
dc.subject
antigenic
en
dc.title
Antigenic diversity in Theileria parva in vaccine stabilate and African buffalo
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
This item appears in the following Collection(s)

